Martin Dahl
Corporate Officer/Principal bei ANAPTYSBIO, INC.
Profil
Martin Dahl is currently working as a Senior Vice President-Research at AnaptysBio, Inc. Previously, he worked as the Global Head-Immunology Network at Takeda Pharmaceuticals U.S.A., Inc. Dr. Dahl completed his undergraduate degree at the University of California, Irvine and holds a doctorate degree from the University of Tokyo.
Aktive Positionen von Martin Dahl
| Unternehmen | Position | Beginn |
|---|---|---|
| ANAPTYSBIO, INC. | Corporate Officer/Principal | 01.01.2018 |
Ehemalige bekannte Positionen von Martin Dahl
| Unternehmen | Position | Ende |
|---|---|---|
Takeda Pharmaceuticals U.S.A., Inc.
 Takeda Pharmaceuticals U.S.A., Inc. Pharmaceuticals: MajorHealth Technology Takeda Pharmaceuticals U.S.A., Inc. develops and markets pharmaceutical products. It offers metabolic and cardiovascular, respiratory and immunology, central nervous system, oncology, and general medicine products. The company was founded in 1998 and is headquartered in Deerfield, IL. | Corporate Officer/Principal | - |
Ausbildung von Martin Dahl
| University of California, Irvine | Undergraduate Degree |
| University of Tokyo | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ANAPTYSBIO, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Takeda Pharmaceuticals U.S.A., Inc.
Takeda Pharmaceuticals U.S.A., Inc. Pharmaceuticals: MajorHealth Technology Takeda Pharmaceuticals U.S.A., Inc. develops and markets pharmaceutical products. It offers metabolic and cardiovascular, respiratory and immunology, central nervous system, oncology, and general medicine products. The company was founded in 1998 and is headquartered in Deerfield, IL. | Health Technology |
